老年脑梗死患者血浆神经肽Y、降钙素基因相关肽水平的动态变化

来源 :中国临床康复 | 被引量 : 0次 | 上传用户:chenzhe1987827
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:观察老年脑梗死患者神经肽Y、降钙素基因相关肽(calcitoningene-relatedpeptide,CGRP)水平改变及其动态变化,探讨神经肽Y、CGRP参与老年脑梗死的病理生理机制及其临床意义。方法:选择老年脑梗死患者42例,依病情轻重分为轻型12例,中型18例,重型12例。依病灶大小分为大灶组22例,小灶组20例。按病程分为≤24h组19例,1~3d组22例、4~7d组27例、8~15d组21例及>15d组18例。按伴发病积分分为<6分组25例与≥6分组17例。按有无高血压史分为有高血压史组18例与无高血压史组24例。选择30例健康老人查体者作为对照组。用放免法检测血浆神经肽Y与CGRP浓度。结果:神经肽Y的变化:老年脑梗死组神经肽Y水平犤(590.66±305.45)ng/L犦显著高于对照组犤(114.76±65.92)ng/L犦(t=5.2846,P<0.0001),于发病后24h内犤(439.13±237.80)ng/L犦显著升高,1~3d犤(668.54±261.44)ng/L犦达高峰,8~15d犤(528.59±215.67)ng/L犦开始下降,15d犤(372.80±200.96)ng/L犦后仍在较高水平;重型犤(698.96±206.85)ng/L犦与大灶组犤(769.61±296.48)ng/L犦显著高于轻型犤(488.60±201.75)ng/L犦与小灶组犤(483.40±312.31)ng/L犦(P<0.01),发病积分≥6分组犤(631.28±286.86)ng/L犦显著高于<6分组犤(573.35±337.64)ng/L犦(t=2.9687,P<0. OBJECTIVE: To observe the changes of neuropeptide Y and calcitonin gene-related peptide (CGRP) levels and their dynamic changes in elderly patients with cerebral infarction and to explore the pathophysiological mechanism of neuropeptide Y and CGRP involved in senile cerebral infarction and its clinical significance. Methods: Forty-two elderly patients with cerebral infarction were selected according to the severity of their illness. They were divided into 12 cases of light, 18 cases of medium and 12 cases of heavy. Divided according to the size of the lesion into a large group of 22 cases, small group of 20 cases. According to the course of disease, there were 19 cases in ≤24h group, 22 cases in 1-3 days group, 27 cases in 4-7 days group, 21 cases in 8-15 days group and 18 cases in> 15 days group. According to the disease points were divided into <6 group of 25 cases and> 6 group of 17 cases. According to whether the history of hypertension is divided into 18 cases of history of hypertension and no history of hypertension in 24 cases. Thirty healthy people were selected as the control group. Radioimmunoassay was used to detect plasma neuropeptide Y and CGRP concentrations. Results: The changes of neuropeptide Y: The level of neuropeptide Y in elderly cerebral infarction group (590.66 ± 305.45 ng / L) was significantly higher than that in control group (114.76 ± 65.92) ng / L 犦 (t = 5.2846, P <0.0001) (439.13 ± 237.80) ng / L 犦 increased significantly at 24h after onset, peaked at 1 ~ 3d 犤 (668.54 ± 261.44) ng / L, reached the peak, and reached peak at 8 ~ 15d 犤 (528.59 ± 215.67) ng / L 犦(372.80 ± 200.96) ng / L 仍, but the levels of heavy 犤 (698.96 ± 206.85) ng / L 犦 and 灶 组 犤 (769.61 ± 296.48) ng / L 犦 were significantly higher than those of the light 犤(483.40 ± 312.31) ng / L 犦 (P <0.01), and the incidence of disease score≥6 group 犤 (631.28 ± 286.86) ng / L 犦 was significantly higher than that of <6 group 48 (488.60 ± 201.75) ng / 573.35 ± 337.64) ng / L 犦 (t = 2.9687, P <0.
其他文献
目的:总结一期前路病灶清除、椎体间植骨及前路内固定治疗脊柱结核的临床疗效,探讨一期重建脊柱稳定性的必要性和安全性.方法:自2000年5月至2003年1月共收治21例脊柱结核患者
目的在静脉吸毒人群队列研究现场,通过6个月随访核实参加者个人联系信息的真实情况初步探讨其影响因素.方法自2003年5~6月在四川省西昌市以社区为基础的HIV阴性的静脉吸毒人群
讨论了一类具有非线性传染力的阶段结构 SI传染病模型 ,确定了各类平衡点存在的阈值条件 ,得到了各类平衡点局部稳定和全局稳定的条件 . A class of SI epidemic model with
目的 观察螺旋藻对实验性变应性鼻炎大鼠血清TH1/TH2细胞因子表达的影响,以探讨其治疗机制.方法用卵清蛋白致敏大鼠制成变应性鼻炎动物模型,口服螺旋藻治疗,观察其行为学差异;组织病理学方法观察鼻黏膜改变;用酶联免疫吸附法(ELISA)对血清中TH1细胞因子IFN-γ、IL-2和TH2细胞因子IL-4、IL-5进行检测.结果行为学得分,阳性对照组(7.8±1.03)明显高于实验组(1.6±1.35)
目的探讨核因子-κB(nuclear factor-κB,NF-κB)在慢性鼻-鼻窦炎黏膜中的表达及活性状态.方法采用免疫组化方法检测18份慢性鼻-鼻窦炎钩突黏膜NF-κB亚单位p50、p65的表达,
目的 通过观察术中脑氧饱和度(rSO2)的变化来探讨非转流下原位肝移植术患者无肝期和新肝早期脑氧供需平衡情况.方法20例行非转流下原位肝移植术的晚期肝病患者采用异氟醚吸入复合异丙酚、芬太尼静脉维持麻醉.术中按需输注乳酸林格氏液、红细胞、血浆和白蛋白,维持红细胞压积≥30%.无肝期适当控制输血、输液,必要时可用多巴胺和肾上腺素维持术中血液动力学稳定.在门、腔静脉开放前开始增加潮气量,避免开放初期动脉
目的:探讨蛛网膜下腔引流治疗Chiari畸形伴脊髓空洞的手术技巧,总结其临床效果.方法:对56例Chiari畸形伴脊髓空洞的患者进行后颅凹减压和蛛网膜下腔引流术.根据引流部位的不
背景和目的外周T细胞淋巴瘤(peripheralT-celllymphoma,PTCL)与B细胞非霍奇金淋巴瘤(non-Hodgkinslymphoma,NHL)相比,往往表现为化疗敏感性差、容易复发、预后不良,目前尚无
目的调查全自动血培养仪分离菌株的特征. 方法从1999~2002年2月我院全自动血培养仪培养的16 322瓶临床血液和无菌体液标本中1 788瓶生长菌,药敏试验按NCCLS纸片扩散法进行,数
目的 观察胎牛血清器官培养液和人脐带血清器官培养液对猪角膜内皮细胞形态学、组织学、超微结构、酶活性及代谢等的影响.方法器官培养方法:4周以内31℃密闭培养,之后脱水24h.选择猪眼113只,其中100只角膜分为两组进行配对器官培养保存.第1组(50只角膜):应用培养液Ⅰ(含10%胎牛血清);第2组(50只角膜,第1组的对侧角膜):应用培养液Ⅱ(含10%人脐带血清).13只角膜作为正常对照.器官培养